ProShares UltraShort NASDAQ Biotechnology
11 hedge funds and large institutions have $4.23M invested in ProShares UltraShort NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0.11% less ownership
Funds ownership: 1.06% → 0.95% (-0.11%)
15% less funds holding
Funds holding: 13 → 11 (-2)
18% less capital invested
Capital invested by funds: $5.17M → $4.23M (-$939K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$418K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$396K |
| 3 |
CT
CMT Trading
Chicago,
Illinois
|
+$223K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$145K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$142K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$495K |
| 2 |
HF
HRT Financial
New York
|
-$411K |
| 3 |
FAM
Fred Alger Management
New York
|
-$245K |
| 4 |
Morgan Stanley
New York
|
-$110K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$104K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $1.39M | +$145K | +614 | +11% |
|
|
VF
2
Virtu Financial
New York
| $719K | +$100K | +425 | +15% |
|
|
3
Jane Street
New York
| $660K | +$418K | +1,773 | +148% |
|
|
4
Citadel Advisors
Miami,
Florida
| $559K | +$396K | +1,677 | +201% |
|
|
VKH
5
Virtu KCG Holdings
New York
| $319K | +$142K | +600 | +72% |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $255K | -$495K | -2,099 | -65% |
|
|
CT
7
CMT Trading
Chicago,
Illinois
| $210K | +$223K | +946 | New |
|
|
8
Morgan Stanley
New York
| $52K | -$110K | -466 | -67% |
|
9
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $39K | – | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $28K | – | – | – |
|
|
FANJ
11
Financial Architects (New Jersey)
Marlton,
New Jersey
| $1K | +$944 | +4 | New |
|
|
HF
12
HRT Financial
New York
| – | -$411K | -1,469 | Closed |
|
|
FAM
13
Fred Alger Management
New York
| – | -$245K | -875 | Closed |
|
|
14
Simplex Trading
Chicago,
Illinois
| – | -$104K | -372 | Closed |
|
15
UBS Group
Zurich,
Switzerland
| – | -$63K | -224 | Closed |
|
BIS Hedge Fund Activity: Q1 2017 in Review
11 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort NASDAQ Biotechnology (BIS) for Q1 2017, worth a combined $4.23M — down 18% from $5.17M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BIS and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was Jane Street, adding an estimated $418K. The largest seller was Susquehanna International Group, cutting an estimated $495K.
- 11 institutional investors held ProShares UltraShort NASDAQ Biotechnology (BIS) as of Q1 2017, down from 13 in Q4 2016.
- Funds reported $4.23M of ProShares UltraShort NASDAQ Biotechnology stock for Q1 2017, down 18% quarter-over-quarter.
- 2 funds opened new ProShares UltraShort NASDAQ Biotechnology positions in Q1 2017 and 4 closed out, a net change of -2 holders.
- The largest ProShares UltraShort NASDAQ Biotechnology buyer in Q1 2017 was Jane Street, an estimated $418K added.
- The largest ProShares UltraShort NASDAQ Biotechnology seller in Q1 2017 was Susquehanna International Group, an estimated $495K sold.
Based on aggregated 13F filings for Q1 2017.